thumbnail
Deal MakingCorner Therapeutics bags $54m to create vaccines with ‘lifelong’ immunityCorner Therapeutics bags $54m to create vaccines with ‘lifelong’ immunity
Immunotherapy firm Corner Therapeutics has raised $54 million in a Series A funding round to develop its antigen agnostic technology and create vaccines against cancer and infectious diseases.